Amar Puttanna

@AmarPut

EPCA 2018 winner, QiC award DIADEM, Diabetes Consultant - frailty,older adults& dementia, cardiovasc disease,medical education

Birmingham, England
rcplondon.ac.uk/about-rcp/whos…
Joined February 2017
599 Photos and videos Photos and videos

Tweets

You blocked @AmarPut

Are you sure you want to view these Tweets? Viewing Tweets won't unblock @AmarPut

  1. Pinned Tweet
    May 4

    Pleasure to ‘complete the set’ and tak through various considerations in these times.

    0:24
    Dr has recorded a series of videos for EASD learning on managing during the pandemic.
    5 retweets 24 likes
    Undo
  2. Retweeted
    1 hour ago

    More good news on immune response, beyond T cells. Neutralizing antibodies from prior infection did the job: in a boat outbreak involving over 100 people, all those with antibodies did not manifest symptoms and were protected from reinfection.

    5 replies 57 retweets 135 likes
    Show this thread
    Show this thread
    Undo
  3. Retweeted
    Aug 14

    Let the world know that you're an supporter 🥰 Simply retweet this tweet by August 20 and we'll add your profile picture to our supporter banners in the EASD Plaza for all to see😃! Register today for the !!

    42 retweets 23 likes
    Undo
  4. Retweeted
    14 hours ago

    A slice of India.... 🇮🇳 Come..and learn about it (NB: Recent change to 28 states for a huge country) Enjoy 🥰

    This media may contain sensitive material. Learn more
    5 replies 7 retweets 47 likes
    Undo
  5. Retweeted
    12 hours ago

    Our study -association of obesity with severe -19 & mortality just published led by

    , , and 7 others
    5 replies 28 retweets 54 likes
    Undo
  6. Retweeted
    21 hours ago

    Perforating the NSAID Harm Hypothesis

    2 retweets 4 likes
    Undo
  7. Retweeted
    Aug 14

    & data in published in -led by Key tips: 1. Done during height of pandemic- bear in mind 2. Have ? Focus on factors you can try to modify 3. Local teams to use data/shape plans accordingly

    , , and 7 others
    7 retweets 12 likes
    Undo
  8. Retweeted
    Aug 14

    Nice article on key methods & issues commonly encountered in comparative observational cohort studies by John Buse et al

    , , and 5 others
    4 retweets 6 likes
    Undo
  9. Retweeted
    Aug 14

    Largest study of over 3 million people with T1 & T2 diabetes in shows the eccess deaths over COVID-19 in 19 weeks 51% increase in T1 deaths (n=672) 64% increase in T2 deaths (n=16071)

    , , and 5 others
    1 reply 42 retweets 59 likes
    Undo
  10. Retweeted
    Aug 14

    Our paper on 61 million people in England published - Type 1 (3.5 fold) & Type 2 (X2 ) diabetes associated with in-hospital COVID-19 deaths But absolute risks overall low especially in young people 27/100,000 for T1 138/100,000 for T2

    , , and 6 others
    4 replies 29 retweets 53 likes
    Undo
  11. Retweeted
    Aug 13

    Here are some resources for management of adrenal insufficiency: Emeregency management and prevention of adrenal crisis guidance Peri-operative management Take home message: don’t forget the steroids.

    4 replies 12 retweets 28 likes
    Show this thread
    Show this thread
    Undo
  12. Retweeted
    Aug 14

    🚨 ANNOUNCEMENT 101 downloaded is LIVE on YouTube! SESSION 5️⃣: 🏋️‍♀️ “Get fit, don’t quit” with A look at hypos and hypers & why they might happen, & importantly how you can avoid these! 🎥

    , , and 7 others
    8 retweets 17 likes
    Undo
  13. Retweeted
    Aug 13

    Hyperglycemia at Hospital Admission Is Associated With Severity of the Prognosis in Patients Hospitalized for COVID-19: The Pisa COVID-19 Study

    1 reply 25 retweets 42 likes
    Undo
  14. Retweeted
    Aug 12

    MODY....or Maturity Onset Diabetes of the Young What should raise your suspicion? Here is some basic information.. And a resource for details- and a calculator to help too! Via

    , , and 7 others
    5 replies 20 retweets 38 likes
    Undo
  15. Aug 12

    Sleep disorders and risk of dementia in patients with new‐onset type 2 diabetes: A nationwide population‐based cohort study

    1 retweet 5 likes
    Undo
  16. Aug 12

    Interesting - Candesartan improved executive function at 12 months! Candesartan vs Lisinopril for Neurocognitive Function in Older Adults With Mild Cognitive Impairment. via part of thanks for highlighting 😉

    , , and 7 others
    6 retweets 16 likes
    Undo
  17. Retweeted
    Aug 12

    ARB telmisartan in high doses demonstrates anti-inflammatory effects & reduced number of days hospitalised with -19 Small Open label RCT

    , , and 7 others
    1 reply 3 retweets 14 likes
    Undo
  18. Retweeted
    Aug 12

    Oral semaglutide available now to prescribe today in the U.K. for people with . First commercially available oral GLP-1 receptor agonist.

    5 replies 33 retweets 82 likes
    Undo
  19. Retweeted
    Aug 11

    Do you have long-term health condition? How has & affected your care? wants to know but its survey closes next Monday. Please spare them 15 mins & fill it in

    , , and 7 others
    1 reply 11 retweets 16 likes
    Undo
  20. Retweeted
    Aug 11

    Mortality from in NOT associated with HbA1c in this 🇺🇸 cohort, but was strongly associated with insulin therapy. This of course may be driven by duration of diabetes and other factors.

    16 retweets 18 likes
    Undo
  21. Retweeted
    Aug 11

    Insulin pumps or glucose sensors cost-effective in T1 people with higher HbA1c levels & rates of hypoglycaemia-systematic reveiw Cost-effectiveness for combined insulin pumps & glucose sensors less clear.

    7 replies 14 retweets 32 likes
    Undo

@AmarPut hasn't Tweeted yet.

Loading seems to be taking a while.

Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.

    You may also like

    ·